Role of circulating adipocytokines vaspin, apelin, and visfatin in the loss of appetite in underweight children: a pilot trial
-
Aysel Vehapoglu
,
Feyza Ustabas
Abstract
Objectives: To investigate serum concentrations of vaspin, apelin, and visfatin in underweight children and their association with anthropometric and nutritional markers of malnutrition.
Subjects and methods: We recruited 44 underweight prepubertal children (youngest age=2 years) with thinness grades of 1, 2, and 3, and body weights <90% of ideal body weight due to loss of appetite and less frequent hunger episodes. Forty-one healthy age- and gender-matched controls were also included in the study. Serum fasting vaspin, apelin, and visfatin concentrations were measured by enzyme immunoassay technique.
Results: Mean vaspin and apelin levels were significantly lower in underweight children compared to controls (vaspin: 0.44±0.18 vs. 0.58±0.35 pg/mL, p=0.024; apelin: 483.37±333.26 vs. 711.71±616.50 pg/mL, p=0.041). Visfatin levels were lower in underweight children compared to controls, but the values were not statistically significant (177.81±158.01 vs. 221.15±212.94 pg/mL, p=0.119).
Conclusions: In underweight children, decreased vaspin and apelin levels should be considered in the etiology of anorexia.
Acknowledgments
The authors of this manuscript would like to thank the children and their mothers who participated in this study.
Financial disclosure: The authors have indicated that they have no financial relationships relevant to this article to disclose.
Funding: No external funding.
Potential conflict of interest: The authors have indicated that they have no potential conflicts of interest to disclose.
References
1. Prendergast AJ, Humphrey JH. The stunting syndrome in developing countries. Paediatr Int Child Health 2014;34:250–65.10.1179/2046905514Y.0000000158Search in Google Scholar PubMed PubMed Central
2. Brinksma A, Roodbol PF, Sulkers E, Hooimeijer HL, Sauer PJ, et al. Weight and height in children newly diagnosed with cancer. Pediatr Blood Cancer 2015;62:269–73.10.1002/pbc.25301Search in Google Scholar PubMed
3. Kadoglou NP, Vrabas IS, Kapelouzou A, Angelopoulou N. The association of physical activity with novel adipokines in patients with type 2 diabetes. Eur J Intern Med 2012;23:137–42.10.1016/j.ejim.2011.10.020Search in Google Scholar PubMed
4. Barraco GM, Luciano R, Semeraro M, Prieto-Hontoria PL, Manco M. Recently discovered adipokines and cardio-metabolic comorbidities in childhood obesity. Int J Mol Sci 2014;15:19760–76.10.3390/ijms151119760Search in Google Scholar PubMed PubMed Central
5. Hida K, Wada J, Eguchi J, Zhang H, Baba M, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005;102:10610–5.10.1073/pnas.0504703102Search in Google Scholar PubMed PubMed Central
6. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998;251:471–6.10.1006/bbrc.1998.9489Search in Google Scholar PubMed
7. Castan-Laurell I, Dray C, Knauf C, Kunduzova O, Valet P. Apelin, a promising target for type 2 diabetes treatment? Trends Endocrinol Metab 2012;23:234–41.10.1016/j.tem.2012.02.005Search in Google Scholar PubMed
8. Bełtowski J. Apelin and visfatin: unique “beneficial” adipokines upregulated in obesity? Med Sci Monit 2006;12:112–9.Search in Google Scholar
9. Grover Z, Ee LC. Protein energy malnutrition. Pediatr Clin North Am 2009;56:1055–68.10.1016/j.pcl.2009.07.001Search in Google Scholar PubMed
10. Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatric Obes 2012;7:284–94.10.1111/j.2047-6310.2012.00064.xSearch in Google Scholar PubMed
11. Blüher M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 2009;117:241–50.10.1055/s-0029-1192044Search in Google Scholar PubMed
12. Blüher M. Adipokines – removing road blocks to obesity and diabetes therapy. Mol Metab 2014;3:230–40.10.1016/j.molmet.2014.01.005Search in Google Scholar PubMed PubMed Central
13. Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev 2011;27:515–27.10.1002/dmrr.1201Search in Google Scholar PubMed
14. Teshigawara S, Wada J, Hida K, Nakatsuka A, Eguchi J, et al. Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population. J Clin Endocrinol Metab 2012;97:1202–7.10.1210/jc.2011-3297Search in Google Scholar PubMed
15. Nourbakhsh M, Nourbakhsh M, Gholinejad Z, Razzaghy-Azar M. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome. Scand J Clin Lab Invest 2015;75:183–8.10.3109/00365513.2014.1003594Search in Google Scholar PubMed
16. Laiguillon MC, Houard X, Bougault C, Gosset M, Nourissat G, et al. Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis. Arthritis Res Ther 2014;16:R38.10.1186/ar4467Search in Google Scholar PubMed PubMed Central
17. Martos-Moreno GÁ, Kratzsch J, Körner A, Barrios V, Hawkins F, et al. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. Int J Obes (Lond) 2011;35:1355–62.10.1038/ijo.2010.280Search in Google Scholar PubMed
18. Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008;57:372–7.10.2337/db07-1045Search in Google Scholar PubMed
19. Brunetti L, Di Nisio C, Recinella L, Chiavaroli A, Leone S, et al. Effects of vaspin, chemerin and omentin-1 on feeding behavior and hypothalamic peptide gene expression in the rat. Peptides 2011;32:1866–71.10.1016/j.peptides.2011.08.003Search in Google Scholar PubMed
20. Klöting N, Kovacs P, Kern M, Heiker JT, Fasshauer M, et al. Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia 2011;54:1819–23.10.1007/s00125-011-2137-1Search in Google Scholar PubMed
21. Castan-Laurell I, Dray C, Attané C, Duparc T, Knauf C, et al. Apelin, diabetes, and obesity. Endocrine 2011;40:1–9.10.1007/s12020-011-9507-9Search in Google Scholar PubMed
22. Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 2000;275:21061–7.10.1074/jbc.M908417199Search in Google Scholar PubMed
23. Kralisch S, Lossner U, Bluher M, Paschke R, Stumvoll M, et al. Growth hormone induces apelin mRNA expression and secretion in mouse 3T3-L1 adipocytes. Regulatory Peptides 2007;139: 84–9.10.1016/j.regpep.2006.10.009Search in Google Scholar PubMed
24. Wei L, Hou X, Tatemoto K. Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regulatory Peptides 2005;132:27–32.10.1016/j.regpep.2005.08.003Search in Google Scholar PubMed
25. Ba HJ, Chen HS, Su Z, Du ML, Chen QL, et al. Associations between serum apelin-12 levels and obesity-related markers in Chinese children. PLoS One 2014;9:e86577.10.1371/journal.pone.0086577Search in Google Scholar PubMed PubMed Central
26. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005;146:1764–71.10.1210/en.2004-1427Search in Google Scholar PubMed
27. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 2008;8:437–45.10.1016/j.cmet.2008.10.003Search in Google Scholar PubMed
28. Krist J, Wieder K, Klöting N, Oberbach A, Kralisch S, et al. Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obesity Facts 2013;6:57–69.10.1159/000348667Search in Google Scholar PubMed PubMed Central
29. Ziora K, Oswiecimska J, Swietochowska E, Ziora D, Ostrowska Z, et al. Assessment of serum apelin levels in girls with anorexia nervosa. J Clin Endocrinol Metab 2010;95:2935–41.10.1210/jc.2009-1958Search in Google Scholar PubMed
30. Reinehr T, Woelfle J, Roth CL. Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: a longitudinal analysis. Metab Clin Exp 2011;60:1349–54.10.1016/j.metabol.2011.02.005Search in Google Scholar PubMed
31. Jin H, Jiang B, Tang J, Lu W, Wang W, et al. Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol. Diabetes Res Clin Pract 2008;79:412–8.10.1016/j.diabres.2007.09.019Search in Google Scholar PubMed
32. Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005;54:2911–6.10.2337/diabetes.54.10.2911Search in Google Scholar PubMed
33. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, et al. Elevated plasma level of visfatin/preYB cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295–9.10.1210/jc.2005-1475Search in Google Scholar PubMed
34. Cinar N, Gurlek A. Association between novel adipocytokines adiponectin, vaspin, visfatin, and thyroid: an experimental and clinical update. Endocrine Connections 2013;2:30–8.10.1530/EC-13-0061Search in Google Scholar PubMed PubMed Central
35. Araki S, Dobashi K, Kubo K, Kawagoe R, Yamamoto Y, et al. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children. Obesity 2008;16:384–8.10.1038/oby.2007.54Search in Google Scholar PubMed
36. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, et al. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 2006;91:1578–81.10.1210/jc.2005-2248Search in Google Scholar PubMed
37. Choi KM, Kim JH, Cho GJ, Baik SH, Park HS, et al. Effect of exercise training on plasma visfatin and eotaxin levels. Eur J Endocrinol 2007;157:437–42.10.1530/EJE-07-0127Search in Google Scholar PubMed
38. Dostálová I, Sedlácková D, Papezová H, Nedvídková J, Haluzík M. Serum visfatin levels in patients with anorexia nervosa and bulimia nervosa. Physiol Res 2009;58:903–7.10.33549/physiolres.931680Search in Google Scholar PubMed
39. Ziora K, Oswiecimska J, Swietochowska E, Ziora D, Stojewska M, et al. Assessment of serum visfatin levels in girls with anorexia nervosa. Clin Endocrinol (Oxf) 2012;76:514–9.10.1111/j.1365-2265.2011.04181.xSearch in Google Scholar PubMed
©2015 by De Gruyter
Articles in the same Issue
- Frontmatter
- Highlight: Growth hormone
- Growth hormone and growth hormone deficiency – still a lot to learn
- Dynamic changes in the hypothalamic- pituitary-adrenal axis during growth hormone therapy in children with growth hormone deficiency: a multicenter retrospective study
- Pituitary gland size is a useful marker in diagnosing isolated growth hormone deficiency in short children
- Carotid intima-media thickness in children treated with growth hormone
- The c.301_302delAG PROP1 gene mutation in Romanian patients with multiple pituitary hormone deficiency
- Growth impairment and growth hormone-IGF-1 axis in infantile anorexia nervosa
- Growth hormone deficiency in a patient with mitochondrial disease
- Perrault syndrome with growth hormone deficiency: a rare autosomal recessive disorder
- Review articles
- Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets
- Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development
- Original articles
- Carotid intimal medial thickness and its relation to endothelial dysfunction and echocardiographic changes in adolescents with type 1 diabetes
- Insulin dynamics and biochemical markers for predicting impaired glucose tolerance in obese Thai youth
- Effects of adolescence-onset hypogonadism on metabolism, bone mineral density and quality of life in adulthood
- Spectrum of clinical presentations and endocrinological findings of patients with septo-optic dysplasia: a retrospective study
- Role of circulating adipocytokines vaspin, apelin, and visfatin in the loss of appetite in underweight children: a pilot trial
- Protein-induced hyperinsulinaemic hypoglycaemia due to a homozygous HADH mutation in three siblings of a Saudi family
- Waist-to-height ratio as a screening measure for identifying adolescents with hypertriglyceridemic waist phenotype
- Assessment and relation of total and regional fat mass with bone mineral content among Indian urban adolescents
- Evaluation of the relationship between serum adropin levels and blood pressure in obese children
- Swallowed glucocorticoid therapy for eosinophilic esophagitis in children does not suppress adrenal function
- Response of vitamin D binding protein and free vitamin D concentrations to vitamin D supplementation in hospitalized premature infants
- Can school health check-ups serve as screening tool for growth anomalies and obesity in children?
- The spectrum of 46XY disorders of sex development in a University centre in Saudi Arabia
- Clinical and molecular characterization of five Spanish kindreds with X-linked adrenal hypoplasia congenita: atypical findings and a novel mutation in NR0B1
- Clinical characteristics of children referred for signs of early puberty before age 3
- Effects of GnRH analogue treatment on anterior pituitary hormones in children with central precocious puberty
- Anti-Müllerian hormone in children: a ten-year prospective longitudinal study (EarlyBird 39)
- Patient reports
- A rare cause of fatal pulmonary alveolar proteinosis: Niemann-Pick disease type C2 and a novel mutation
- Migratory polyarthritis as an adverse effect of thiamazole use in a 13-year-old girl with Graves’ disease
- Dyshormonogenesis seems to be more frequent in a group of Cameroonian children with congenital hypothyroidism
- Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up
- Cerebral infarction and femoral venous thrombosis detected in a patient with diabetic ketoacidosis and heterozygous factor V Leiden G1691A and PAI-1 4G/5G mutations
- Combined adrenal failure and testicular adrenal rest tumor in a patient with nicotinamide nucleotide transhydrogenase deficiency
- Short communication
- Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome
- Letters to the Editor
- Psychiatric disorders are associated with increased risk for developing hyponatraemia in children
- Rett syndrome and precocious puberty association
Articles in the same Issue
- Frontmatter
- Highlight: Growth hormone
- Growth hormone and growth hormone deficiency – still a lot to learn
- Dynamic changes in the hypothalamic- pituitary-adrenal axis during growth hormone therapy in children with growth hormone deficiency: a multicenter retrospective study
- Pituitary gland size is a useful marker in diagnosing isolated growth hormone deficiency in short children
- Carotid intima-media thickness in children treated with growth hormone
- The c.301_302delAG PROP1 gene mutation in Romanian patients with multiple pituitary hormone deficiency
- Growth impairment and growth hormone-IGF-1 axis in infantile anorexia nervosa
- Growth hormone deficiency in a patient with mitochondrial disease
- Perrault syndrome with growth hormone deficiency: a rare autosomal recessive disorder
- Review articles
- Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets
- Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development
- Original articles
- Carotid intimal medial thickness and its relation to endothelial dysfunction and echocardiographic changes in adolescents with type 1 diabetes
- Insulin dynamics and biochemical markers for predicting impaired glucose tolerance in obese Thai youth
- Effects of adolescence-onset hypogonadism on metabolism, bone mineral density and quality of life in adulthood
- Spectrum of clinical presentations and endocrinological findings of patients with septo-optic dysplasia: a retrospective study
- Role of circulating adipocytokines vaspin, apelin, and visfatin in the loss of appetite in underweight children: a pilot trial
- Protein-induced hyperinsulinaemic hypoglycaemia due to a homozygous HADH mutation in three siblings of a Saudi family
- Waist-to-height ratio as a screening measure for identifying adolescents with hypertriglyceridemic waist phenotype
- Assessment and relation of total and regional fat mass with bone mineral content among Indian urban adolescents
- Evaluation of the relationship between serum adropin levels and blood pressure in obese children
- Swallowed glucocorticoid therapy for eosinophilic esophagitis in children does not suppress adrenal function
- Response of vitamin D binding protein and free vitamin D concentrations to vitamin D supplementation in hospitalized premature infants
- Can school health check-ups serve as screening tool for growth anomalies and obesity in children?
- The spectrum of 46XY disorders of sex development in a University centre in Saudi Arabia
- Clinical and molecular characterization of five Spanish kindreds with X-linked adrenal hypoplasia congenita: atypical findings and a novel mutation in NR0B1
- Clinical characteristics of children referred for signs of early puberty before age 3
- Effects of GnRH analogue treatment on anterior pituitary hormones in children with central precocious puberty
- Anti-Müllerian hormone in children: a ten-year prospective longitudinal study (EarlyBird 39)
- Patient reports
- A rare cause of fatal pulmonary alveolar proteinosis: Niemann-Pick disease type C2 and a novel mutation
- Migratory polyarthritis as an adverse effect of thiamazole use in a 13-year-old girl with Graves’ disease
- Dyshormonogenesis seems to be more frequent in a group of Cameroonian children with congenital hypothyroidism
- Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up
- Cerebral infarction and femoral venous thrombosis detected in a patient with diabetic ketoacidosis and heterozygous factor V Leiden G1691A and PAI-1 4G/5G mutations
- Combined adrenal failure and testicular adrenal rest tumor in a patient with nicotinamide nucleotide transhydrogenase deficiency
- Short communication
- Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome
- Letters to the Editor
- Psychiatric disorders are associated with increased risk for developing hyponatraemia in children
- Rett syndrome and precocious puberty association
